Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.97M Buy
5,600
+10
+0.2% +$3.56K 1.05% 47
2025
Q4
$1.83M Sell
5,590
-260
-4% -$82.5K 0.98% 45
2025
Q3
$1.65M Buy
5,850
+126
+2% +$36.5K 0.89% 49
2025
Q2
$1.6M Buy
5,724
+276
+5% +$78.2K 0.92% 53
2025
Q1
$1.7M Sell
5,448
-145
-3% -$42.8K 1.1% 41
2024
Q4
$1.46M Buy
5,593
+910
+19% +$270K 0.88% 51
2024
Q3
$1.51M Sell
4,683
-185
-4% -$60.5K 0.93% 45
2024
Q2
$1.52M Buy
4,868
+6
+0.1% +$1.76K 0.98% 38
2024
Q1
$1.38M Sell
4,862
-67
-1% -$19.6K 0.93% 48
2023
Q4
$1.42M Buy
+4,929
New +$1.34M 1.02% 40

Other funds holding AMGN

Boomfish Wealth Group's AMGN Position: Q1 2026 in Review

Boomfish Wealth Group increased its Amgen (AMGN) stake by 0.18% in Q1 2026, buying an estimated $3.56K and bringing the position to 5,600 shares worth $1.97M. The position accounts for 1.05% of the portfolio, ranked #47.

Boomfish Wealth Group first reported a position in AMGN in Q4 2023 and has held it in 10 quarters since. 3,131 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Boomfish Wealth Group held 5,600 shares of Amgen worth $1.97M as of Q1 2026.
  • Boomfish Wealth Group bought 10 Amgen shares in Q1 2026, an estimated $3.56K.
  • Amgen made up 1.05% of Boomfish Wealth Group's portfolio in Q1 2026, its #47 holding.
  • Boomfish Wealth Group first reported a position in Amgen in Q4 2023 and has held it in 10 quarters since.
  • 3,131 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Boomfish Wealth Group's 13F filing for Q1 2026, filed 22 Apr 2026.